Assessment of TetraSOD® Efficacy to Improve Semen Parameters in Men With Idiopathic Infertility
A Double-blind Randomized Placebo-controlled Clinical Study to Verify the Efficacy of TetraSOD® in the Improvement of Semen Quality in Patients With Idiopathic Infertility
Sponsor: Fertypharm
This NA trial investigates Infertility, Male and is currently completed. Fertypharm leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Sep 2024 — Apr 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2021 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
May 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fertypharm
- Fitoplancton Marino, S.L.
- Fundacio Clinic Barcelona
For direct contact, visit the study record on ClinicalTrials.gov .